Hypothetical Preclinical Alzheimer’s Disease Groups and Longitudinal Cognitive Change

IMPORTANCE AND OBJECTIVE: Clinical trials testing treatments for Alzheimer’s disease (AD) are increasingly focused on cognitively normal individuals in the preclinical phase of the disease. To optimize observing a treatment effect, such trials need to enroll cognitively normal individuals likely to...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JAMA Neurol
Egile Nagusiak: Soldan, Anja, Pettigrew, Corinne, Cai, Qing, Wang, Mei-Cheng, Moghekar, Abhay, O’Brien, Richard, Selnes, Ola, Albert, Marilyn
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5173327/
https://ncbi.nlm.nih.gov/pubmed/27064267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2016.0194
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak